Scroll Top

The New Weight Loss Question: What Is Your Body Keeping?

The New Weight Loss Question: What Is Your Body Keeping?

How GLP-1 medications, hormone therapy, nutrition, strength training, and peptide discussions fit into a more complete body composition plan.

Person administering a GLP-1 injection as part of a medically supervised weight-loss plan

For years, weight loss success was measured by one number: the number on the scale. If it went down, the plan appeared to be working.

GLP-1 medications have changed what is possible for many adults living with obesity, insulin resistance, Type 2 diabetes, persistent hunger, or weight that has stopped responding to familiar approaches. Appetite may become easier to manage, cravings may decrease, and meaningful weight loss may become more attainable. Advanced Anti-Aging offers medically supervised weight-loss injections for eligible adults following a provider evaluation.

As results improve, the conversation is becoming more complete. Patients and medical providers are asking what kind of weight is being lost and how treatment may affect muscle, strength, energy, and recovery.

For adults considering GLP-1 weight loss, hormone therapy, or peptide therapy, the goal should extend beyond a smaller number on the scale. A medically guided plan should also consider body composition, metabolic health, physical function, and how the patient wants to feel during and after treatment.

Why Does Muscle Matter During GLP-1 Weight Loss?

Weight loss usually includes a combination of fat mass and lean mass. Lean mass includes muscle, organs, connective tissue, and body water, so a change in lean mass does not represent muscle loss alone. Maintaining skeletal muscle remains an important part of protecting strength, mobility, metabolic health, and long-term physical function.

Body composition analyses from clinical trials of semaglutide and tirzepatide found that participants lost more fat mass than lean mass. They also showed that some lean mass reduction can occur during significant weight loss.1, 2 The amount varies based on the individual, medication, rate of weight loss, nutrition, physical activity, age, and starting body composition.

This changes the question from “How much weight did I lose?” to “How much fat did I lose, and how well did I maintain my strength?” Adults concerned about changes in strength or body composition can also read about the clinic’s approach to muscle loss and hormone health.

For police officers and other first responders, as well as healthcare workers, tradespeople, athletes, parents, and adults with physically demanding schedules, this distinction can be especially relevant. Their goals may include reducing excess fat while maintaining the strength, stamina, and recovery needed for work and daily life.

How Can Patients Protect Lean Muscle While Losing Weight?

GLP-1 medications can help regulate appetite and support weight loss. The habits that help maintain healthy tissue remain an essential part of treatment.

A complete medical weight-loss plan may include:

  • Adequate protein based on the patient’s health, body size, activity level, and kidney function
  • Consistent resistance training suited to the patient’s ability and experience
  • Sufficient calories and nutrients during periods of reduced appetite
  • Sleep and recovery support
  • Hydration and electrolyte management
  • Regular laboratory testing
  • Medication adjustments based on response and side effects
  • Body composition or strength monitoring when appropriate

Rapid weight loss, very low food intake, and a lack of resistance training can make lean tissue more difficult to maintain. Medical follow-up gives the provider an opportunity to evaluate how the patient is responding beyond the scale.

Where Does Hormone Therapy Fit?

Fatigue, reduced strength, slower recovery, sleep disruption, weight changes, low libido, and changes in mood can overlap with symptoms associated with hormone imbalance. They can also be related to stress, nutritional deficiencies, medication effects, thyroid concerns, poor sleep, or other medical conditions.

Hormone therapy should begin with a clinical evaluation and appropriate laboratory testing.

For men with symptoms and confirmed testosterone deficiency, testosterone replacement therapy and BHRT for men may be considered after reviewing medical history, laboratory results, treatment goals, risks, and monitoring requirements. TRT is a treatment for appropriately diagnosed hormone deficiency. It is not a general weight-loss medication or an automatic addition to GLP-1 treatment. Patients can also review the clinic’s information about low testosterone evaluation and treatment.

Women experiencing symptoms associated with perimenopause or menopause may discuss bioidentical hormone replacement therapy for women with a qualified provider. Treatment decisions should reflect symptoms, medical history, individual risk factors, and ongoing monitoring.

When hormone therapy is clinically appropriate, addressing hormone balance may help a patient feel more capable of exercising, recovering, sleeping, and following a sustainable health plan. Nutrition and resistance training remain central to preserving muscle during weight loss.

For a closer look at how these areas may overlap, read How Weight-Loss Medications and Hormone Therapy Work Together.

What Is Peptide Therapy?

Peptides are short chains of amino acids involved in many forms of cellular signaling. The term “peptide therapy” covers a wide range of substances with different uses, evidence, safety profiles, and regulatory classifications.

Some peptide-based medications are FDA-approved for specific medical conditions. Other peptides discussed in wellness and anti-aging settings have limited human research and no FDA-approved indication.

This distinction matters. Peptides should be reviewed individually by a licensed medical provider. Patients who want a broader introduction can read Understanding Peptide Therapy and Hormone Replacement Therapy.

Can Tesamorelin Be Used for General Weight Loss?

Tesamorelin is a growth hormone-releasing factor analog. The FDA-approved tesamorelin product is indicated for reducing excess abdominal fat in adults with HIV-associated lipodystrophy.

It is not approved for general weight management, and the prescribing information describes it as weight neutral.3 Its approved indication should not be confused with routine treatment for obesity or with evidence that it preserves muscle during GLP-1 therapy.

What Should Patients Know About Ipamorelin?

Ipamorelin is a growth hormone secretagogue that stimulates growth hormone release through specific signaling pathways. It is sometimes discussed in connection with body composition, sleep, recovery, and lean tissue.

Ipamorelin does not have an FDA-approved indication for weight loss or preserving muscle during GLP-1 treatment. FDA materials also identify safety and quality concerns related to compounded ipamorelin acetate, including limited information for some injectable routes.4

Current evidence does not establish that adding ipamorelin to semaglutide or tirzepatide prevents muscle loss. Any discussion should include its regulatory status, limitations in the available evidence, potential risks, and the patient’s complete medical history.

What About BPC-157 and TB-500?

BPC-157 and TB-500 are frequently promoted online for injury recovery, connective tissue support, inflammation, and physical performance. These claims often go further than the available human evidence.

Neither BPC-157 nor TB-500 has an FDA-approved indication for injury recovery, weight management, or muscle preservation. The FDA has reported limited human safety information and potential concerns involving immunogenicity, peptide impurities, product characterization, and compounded formulations.4

In July 2026, the FDA’s Pharmacy Compounding Advisory Committee reviewed BPC-157-related and TB-500-related substances for possible inclusion on the 503A Bulks List. FDA’s published briefing materials proposed that these substances should not be included.5 The review does not represent FDA approval of either peptide, a compounded product, or a multi-peptide blend.

Can Peptides Preserve Muscle During GLP-1 Treatment?

There is currently insufficient clinical evidence to conclude that ipamorelin, BPC-157, TB-500, or a multi-peptide blend preserves muscle in patients using GLP-1 medications.

Patients interested in protecting lean mass should begin with approaches supported by stronger evidence: adequate nutrition, resistance training, appropriate medication dosing, medical monitoring, and an evaluation for underlying conditions that may affect muscle, energy, or recovery.

A medical provider can also determine whether symptoms justify hormone testing or another clinical evaluation. Peptides should not be used as a substitute for these foundations.

A More Complete Approach to Weight Management

The most appropriate treatment plan depends on the individual.

A patient using semaglutide or tirzepatide may benefit from nutritional guidance, strength training, laboratory monitoring, and periodic evaluation of physical function. A man experiencing symptoms of low testosterone may need a separate hormone assessment. A woman navigating perimenopause or menopause may benefit from a conversation about BHRT, bone health, sleep, muscle, and metabolic changes.

These treatments may appear in the same health conversation, though each requires its own clinical rationale. Combining therapies without a proper evaluation can introduce unnecessary risk and may distract from the factors most likely to improve long-term results.

Advanced Anti-Aging provides medically supervised evaluations for adults considering GLP-1 weight-loss treatment, testosterone replacement therapy, bioidentical hormone replacement therapy, and peptide therapy where legally available and clinically appropriate.

Programs are based on symptoms, laboratory testing, medical history, treatment goals, provider evaluation, and ongoing monitoring. Consultations may be available to eligible patients in New Jersey, New York, Texas, and Florida, subject to provider licensure and state treatment requirements.

Frequently Asked Questions

Do GLP-1 medications cause muscle loss?

Significant weight loss can include reductions in both fat mass and lean mass. Clinical studies generally show greater fat loss, although some lean mass reduction can occur. Nutrition, resistance training, age, activity level, and the rate of weight loss can influence body composition.

Is testosterone replacement therapy a weight-loss treatment?

TRT is prescribed for appropriately evaluated men with testosterone deficiency. It is not approved as a general weight-loss treatment. When clinically appropriate, addressing low testosterone may help with symptoms that affect exercise, recovery, and adherence to a health plan.

Can women use hormone therapy during medical weight loss?

Some women experiencing perimenopause or menopause may be candidates for hormone therapy based on their symptoms, health history, and risk factors. BHRT should be evaluated separately from weight-loss treatment and monitored by a qualified provider.

Is tesamorelin approved for weight loss?

No. Tesamorelin is FDA-approved for reducing excess abdominal fat in adults with HIV-associated lipodystrophy. It is not indicated for general weight management.

Are ipamorelin, BPC-157, and TB-500 FDA-approved?

These peptides do not have FDA-approved indications for general weight loss, muscle preservation, or injury recovery. Patients should discuss the limited evidence, regulatory status, product quality, and potential risks with a licensed provider.

Can police officers and first responders receive hormone or weight-loss treatment?

Police officers, first responders, and other shift workers may be evaluated using the same medical criteria as other patients. Their work schedule, sleep patterns, physical demands, stress, medical history, symptoms, and laboratory results can inform the treatment discussion.

Is telehealth available in New Jersey, New York, Texas, and Florida?

Telehealth availability depends on the patient’s location, provider licensure, medical eligibility, and state requirements. Advanced Anti-Aging can confirm current availability during the initial consultation.

Related care: Weight-Loss Injections, BHRT for Men, BHRT for Women, and Muscle Loss and Hormone Health.

Start With a Medical Evaluation

Talk with Advanced Anti-Aging about your symptoms, laboratory testing, body composition goals, and treatment options.

Request a Consultation

Call 973-998-7770 or email info@advancedantiaging.com and ask for Lisa.

Medical References

  1. STEP 1 semaglutide body composition analysis
  2. SURMOUNT-1 tirzepatide body composition analysis
  3. FDA prescribing information for tesamorelin
  4. FDA review of compounded substances with potential safety risks
  5. FDA July 2026 Pharmacy Compounding Advisory Committee materials

This article is for general educational purposes and does not replace an individual medical evaluation, diagnosis, or treatment plan. Treatment availability and eligibility vary by patient and location.